Consensus was also reached that cardiometabolic complications and comorbidities, including residual HbA1c elevation, BMI elevation and ASCVD development, could drive a decision to add GLP-1 RA to SGLT2i therapy, tailored to individual patient characteristics and preference
Covered by Major Insurance Plans Coverage options for tirzepatide vary, but many major insurers like United Healthcare, Blue Cross Blue Shield, Cigna, and state Medicaid plans often cover this weight loss medication with prior authorization
Theyre a clinical breakthrough thats rapidly transforming both consumer behavior and product expectations across the food and beverage landscape. Distinct groups of GLP-1 users According to IFF, food and beverage manufacturers need to think about the different needs of three consumer groups: active users of the medications, those transitioning off the drugs, and those seeking to sustain results after coming off the drugs
In this way, exercise can make GLP-1 drugs more effective